Pulmonary arterial hypertension (PAH) is a life-threatening disorder of the pulmonary circulation associated with loss and impaired regeneration of microvessels. Reduced pericyte coverage of pulmonary microvessels is a pathological feature of PAH and is caused partly by the inability of pericytes to respond to signaling cues from neighboring pulmonary microvascular endothelial cells (PMVECs). We have shown that activation of the Wnt/planar cell polarity pathway is required for pericyte recruitment, but whether production and release of specific Wnt ligands by PMVECs are responsible for Wnt/planar cell polarity activation in pericytes is unknown.
P
ericytes are specialized perivascular cells embedded in the basement membrane of blood vessels where, in conjunction with neighboring endothelial cells (ECs), they support vessel maturation and stability. [1] [2] [3] In the lung, pericytes are mostly found to be associated with small precapillary arteries (<30 µm), capillaries (≈10 µm), and postcapillary venules. It is thought that pericytes are responsible for regulation of vasomotor tone and structural support of microvessels. 4 When these vessels become muscularized, pulmonary vascular resistance increases, resulting in pulmonary arterial hypertension (PAH), a life-threatening disorder associated with a progressive rise in pulmonary pressures resulting from loss of small peripheral pulmonary arteries, occlusion of larger proximal pulmonary arteries caused by proliferation of smooth muscle cells, and deposition of extracellular matrix. 5 Efforts to elucidate the mechanisms related to small vessel loss in PAH have centered mostly on pulmonary ECs, smooth muscle cells, and fibroblasts, but not much was known about the contribution of pulmonary pericytes to PAH pathobiology until recently.
Work by our group and others has opened a window into the dynamic and complex role that pericytes play in the initiation and progression of vascular remodeling in PAH. For instance, a study by Ricard and colleagues 6 reported increased pericyte numbers in close proximity to small and medium-sized remodeled pulmonary microvessels in explanted PAH lungs. Pericytes purified from PAH lungs display a proproliferative and promigratory phenotype in culture when exposed to endothelium-derived fibroblast growth factor-2. Chang and colleagues 7 explored this further using a perlecan heparan sulfate-deficient mouse model, demonstrating reduced pericyte recruitment to intraacinar vessels in conjunction with reduced fibroblast growth factor-2 production under hypoxia. Given the role of pericytes in promoting the growth and maturation of microvessels, we predicted that failure of pericytes to associate with ECs in PAH could contribute to small vessel loss by preventing proper vascular growth, structural stability, and survival. Using several complementary approaches, we demonstrated that PAH pericytes fail to associate with healthy pulmonary microvascular ECs (PMVECs) in coculture and decided to characterize the molecular mechanisms that drive pericyte recruitment to pulmonary microvessels. Transcriptome analysis of lung pericytes revealed upregulation in Fzd7 and cdc42, 2 genes involved in the Wnt/ planar cell polarity (PCP) pathway that is responsible for coordinating complex cell movements during tissue morphogenesis. 8 Our studies demonstrated that restoration of Wnt/PCP in PAH pericytes could partially restore recruitment to PMVECs and increase vessel stability. Although these observations support an essential role for Wnt/PCP as a key regulator of endothelium-pericyte communication, how ECs trigger Wnt/PCP activation to initiate pericyte recruitment and whether there is a disruption of Wnt ligand production in PAH PMVECs remain unknown.
In this study, we demonstrate for the first time that Wnt5a production by PMVECs is an important step in initiating the migration of pericytes toward areas of new vessel growth and that stunted Wnt5a production by PAH PMVECs results in a lack of appropriate pericyte recruitment. We also show that PMVECs package Wnt5a in exosomes, which serve as vectors for transporting Wnt5a to neighboring pericytes. Most important, we show that Wnt5a-enriched exosomes can be harvested from healthy PMVECs and used to partially restore pericyte recruitment in PAH PMVECs. Finally, we show that mice with Wnt5a knockout (KO) restricted to ECs demonstrate persistent pulmonary hypertension and right-sided heart failure after recovery from hypoxia and that this correlates with reduced pericyte coverage of small (<50 µm) vessels. Taken together, the results of our study provide evidence that Wnt5a production by PMVECs is required for pericyte recruitment to small vessels and that its loss contributes to vessel loss in PAH. We speculate that therapeutic strategies
Clinical Perspective
What Is New?
• Pulmonary microvascular endothelial cells isolated from patients with pulmonary arterial hypertension and endothelium from pulmonary arterial hypertension tissue have reduced expression of Wnt5a.
• Healthy pulmonary microvascular endothelial cells produce and package Wnt5a in forms of exosomes that regulate pericyte recruitment, motility, and polarity.
• Chronic hypoxic mice lacking Wnt5a in endothelium demonstrate persistent pulmonary hypertension, right-sided heart failure, and reduced pericyte coverage after reoxygenation.
What Are the Clinical Implications?
• We uncover a key role for Wnt5a in establishing pulmonary microvascular endothelial cell and pericyte interaction in distal vessels, iterating that its loss could contribute to progressive vessel remodeling in pulmonary arterial hypertension.
• We provide a new mechanism by which Wnt5a is produced in exosomes in pulmonary microvascular endothelial cells.
• We address promising therapeutic strategies for the restoration of Wnt/planar cell polarity pathway in endothelium-pericyte communication, which will help prevent microvessel loss in pulmonary arterial hypertension.
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capable of restoring Wnt/PCP activity in the pulmonary circulation could help prevent loss or facilitate small vessel regeneration in PAH.
METHODS
An expanded Materials and Methods section containing a detailed description of reagents, techniques, and assays is provided in the online-only Data Supplement. The authors declare that all supporting data are available within the article (and its online supplementary files). Institutional Review Board approval was obtained, according to the guidelines noted in our institutions to authors. All procedures performed in animals were in accordance with institutional guidelines. Clinical information can be found in Table I in the online-only Data Supplement, and the primer sequences used in the study can be found in Table II in the online-only Data Supplement.
Statistical Analysis
The number of samples or animals studied per experiment is indicated in the figure legends. Values from multiple experiments are expressed as mean±SEM. Statistical significance was determined with unpaired t tests or 1-way ANOVA followed by Dunnett or Bonferroni multiple-comparison tests unless stated otherwise. A value of P<0.05 was considered significant.
RESULTS

PAH PMVECs Fail to Recruit Healthy Lung Pericytes in a Matrigel Coculture Model
Recruitment of pericytes by ECs is a key step in angiogenesis because it results in stabilization of newly formed vessels. 3 To test the capacity of healthy and PAH PMVECs to recruit pericytes, we cocultured healthy human lung pericytes with either healthy donor or PAH PMVECs at a 5:1 ratio in Matrigel, a biological matrix that promotes tube-like structure formation by ECs in vitro. 9 Compared with PMVECs alone ( Figure 1A , top), coculture with healthy lung pericytes resulted in a significant increase in total tube length, total branching points, and number of loops ( Figure 1B) . In contrast, coculture of healthy lung pericytes with PAH PMVECs under the same conditions resulted in a vascular network that was no different in size compared with that seen when PMVECs were cultured alone ( Figure 1A , bottom). To determine whether the observed differences in network size were the result of alterations in pericyte distribution, we used cell membrane dyes to stain pericytes (PKH26, red) and PMVECs (PKH67, green) before seeding in Matrigel coculture. We found that healthy pericytes established contacts with ECs mostly over the length of the vascular tubular structure ( Figure 1A , top inset), whereas PAH pericytes tended to remain clustered within vascular nodes, resulting in thinner vascular tube-like structures ( Figure 1A , bottom inset). Taking these results together, we found an apparent lack of migration and polarization of pericytes toward the endothelial tube-like structure generated by PAH PMVECs. This is interesting because this phenotype is reminiscent of the behavior seen when PAH pericytes are cultured with healthy PMVECs. 
Healthy Lung Pericytes Display Reduced Migration and Polarization Toward PAH PMVECs
Extensive work has shown that recruitment of pericytes to developing vessels is the result of endothelium-released factors that direct pericyte polarization toward the vascular tubes. 1, 10 Because Matrigel is a substrate that contains a multitude of cytokines that could confound analysis of chemotactic factors, we used 2 complementary assays to narrow the contribution of endothelium-derived factors to pericyte recruitment. In the Boyden chamber assay, we seeded either healthy donor or PAH PMVECs on the bottom chambers of 24-well culture plates, along with an inner chamber containing healthy lung pericytes seeded at top of an 8-µm porous membrane. As anticipated, healthy pericytes spontaneously transmigrated in significantly greater numbers in the presence of healthy but not PAH PMVECs ( Figure 1C ). To further link the PMVEC-induced mobilization of pericytes to cytoskeletal rearrangements required for their polarization, we cocultured PMVECs and pericytes in a dual-chamber slide that creates a gap between both cell groups akin to that of a wound-healing assay. Pericentrin, a protein located within the microtubule organization center at the migrating front end, was used to measure the degree of cell polarization in pericytes. After 6 hours, close to 40% of healthy pericytes demonstrated polarization toward the healthy PMVEC monolayer and migrated ≈200 µm from their starting point at 0 hours ( Figure 1D , left top and bottom). In contrast, healthy pericytes demonstrated only ≈20% polarization and migrated significantly less in the presence of PAH PMVECs ( Figure 1D , right top and bottom).
Pericytes Induce Wnt5a Production in Healthy but Not PAH PMVECs
Previous work by our group identified the Wnt/PCP pathway as a major player in coordinating pericyte recruitment to PMVECs because mutations in genes coding for Wnt/PCP receptors and signaling mediators in PAH pericytes blunted recruitment to healthy PMVECs. 8 Given that we observed a similar phenotype with cocultures of PAH PMVECs and healthy lung pericytes, we sought to compare the expression of well-characterized Wnt ligands in healthy versus PAH PMVECs seeded alone and in coculture. Both healthy and PAH PMVECs demonstrated upregulation in transforming growth factor-β and platelet-derived growth factor-BB gene expression, an expected finding given that these 2 molecules are known to coordinate establishment of endotheliumpericyte interactions during angiogenesis. 11 Compared with cells in monoculture, healthy PMVECs demonstrated a ≈35-fold increase in Wnt5a expression, a response that was missing in PAH PMVECs under similar culture conditions ( Figure 2A ). Likewise, Western immunoblotting (WB) of lysates from healthy PMVECs showed a significant increase in Wnt5a expression in coculture that was reduced in PAH PMVECs ( Figure 2B To confirm our cell culture findings, we sought to identify the expression pattern of Wnt5a in lung microvessels and PMVECs isolated from healthy donor and PAH lungs obtained at the time of transplantation. Immunohistochemistry revealed a strong Wnt5a signal in the endothelium of healthy microvessels but not in PAH lesions ( Figure II in the online-only Data Supplement). Likewise, immunofluorescence of healthy donor lung sections revealed strong expression of Wnt5a in endothelium ( Figure 2C , left), which correlated with adequate pericyte coverage identified via 3G5, a pericyte marker ( Figure 2D , left, white arrows). However, in the endothelium found within PAH vascular lesions, Wnt5a expression was noticeably reduced ( Figure 2C , right), and although pericytes were still observed in the vicinity, they were disassociated from endothelium, resulting in reduced perivascular coverage ( Figure 2D , right). Because no significant differences in expression pattern of Wnt expression were found in the human whole-lung lysates ( Figure IB in the online-only Data Supplement), we isolated PMVECs using magnetic beads and confirmed via WB a >3-fold reduction in Wnt5a protein expression in PAH PMVECs from unrelated individuals compared with cells from healthy donors isolated under similar conditions ( Figure 2E ). It is worth pointing out that Wnt5a expression was also reduced in the endothelium of medium-sized (200-500 µm) vessels ( Figure  III in the online-only Data Supplement), which also exhibited a reduced number of pericytes near the intima ( Figure IV in the online-only Data Supplement).
As part of our investigation, we also looked at the lungs of sugen/hypoxia rats 11 for evidence of reduced Wnt5a endothelial expression in vascular lesions. Indeed, we discovered that Wnt5a expression was found predominantly in the endothelium of healthy vessels in wild-type (WT) rats, along with appropriate pericyte coverage ( Figure V , top, in the online-only Data Supplement). As predicted from our human studies, Wnt5a was mostly absent from ECs in vascular lesions of sugen/hypoxia rats and correlated with dissociated pericytes ( Figure V , bottom, in the online-only Data Supplement).
Reduction of Wnt5a Production Results in Reduced Pericyte Recruitment to Healthy PMVECs.
As a member of the Wnt family of ligands, Wnt5a is a well-known activator of the Wnt/PCP pathway that helps coordinate cell polarization and complex movements during tissue morphogenesis and repair in response to injury. 12, 13 In a previous study, we demonstrated that stimulation of healthy pericytes with recombinant Wnt5a resulted in Wnt/PCP-dependent pericyte motility, as evidenced by downstream RhoA/ Rac1/cdc42 activity, 8 but whether endogenous production of Wnt5a by PMVECs could recapitulate these effects was not explored. To test whether loss of Wnt5a production in PAH PMVECs could account for their inability to appropriately recruit pericytes, we used siRNA transfection to knock down Wnt5a in healthy PMVECs to levels comparable to those in PAH cells ( Figure 3A ) and performed Boyden and modified wound-healing assays. Similar to PAH PMVECs, pericytes demonstrated significantly reduced migration and polarization toward Wnt5a siRNA-treated (siWnt5a) PMVECs in both Boyden ( Figure 3B ) and wound ( Figure 3C-3E ) coculture assays, which was rescued by adding recombinant Wnt5a. On the other hand, addition of a neutralizing Wnt5a antibody with siWnt5a further abrogated pericyte motility and polarity (Figure VI in the online-only Data Supplement).
To further assess the impact of Wnt5a deficiency on angiogenesis, we seeded either nontargeting (siCtrl) or siWnt5a-transfected healthy PMVECs on Matrigel alone or in coculture with healthy pericytes. In contrast to siCtrl-transfected cells, the size of the vascular tube-like network formed by siWnt5a PMVECs in a single culture was significantly smaller, as evidenced by reduced total tube length, branching points, and number of loops ( Figure 3F , first 2 panels). As anticipated, siWnt5a PMVECs were unable to recruit healthy pericytes, as evidenced by the reduced number of pericytes associated with endothelial tube-like structure and the smaller size of the tube-like networks ( Figure 3F, fourth panel) . Similar to its effect on Boyden and modified woundhealing assays, the addition of recombinant Wnt5a to the siWnt5a PMVEC coculture resulted in a significant increase in pericyte association and larger tube-like networks ( Figure 3F, fifth panel) . The same findings were recapitulated in a fibrin gel bead assay, 14 
Wnt5a Produced by PMVECs Is Released to the Extracellular Space in Exosomes
Originally thought to work in either autocrine and paracrine fashion, Wnts can also have long-range effects, which is counterintuitive given that lipid-rich moieties limit their diffusion in the extracellular space. 15 This apparent paradox has recently been solved by the discovery that Wnts can be packaged into exosomes that are trafficked between cells and help maintain the biological activity of the ligand. 16, 17 Evidence that Wnt5a is being packaged into exosomes was observed when PMVECs were stained for Wnt5a when cultured alone or in the presence of pericytes seeded in Boyden chambers ( Figure 4A ). Compared with the diffuse pattern seen in monoculture, Wnt5a in healthy PMVECs exposed to pericytes was organized into dense particles dispersed across the cytoplasm and heavily clustered in the membrane ruffles ( Figure 4A, top 2 panels) . In contrast, PAH PMVECs had a low-grade Wnt5a expression in monoculture, which was expected given the documented low Wnt5a production in these cells. In addition, no demonstrable change in Wnt5a signal intensity or distribution was seen in coculture ( Figure 4A , bottom 2 panels). On the basis of these observations, we decided to isolate exosomes to compare the Wnt5a content and biological activity between healthy and PAH PMVECs.
The most commonly used approach for exosome purification is ultracentrifugation, but its major drawback is that it requires abundant source material. Our group has recently developed ExoTIC, 18 a novel technology to isolate exosomes from biological fluids using a Although we saw a similar trend in PAH PMVECs coculture, the exosome concentration was reduced (data not shown). Using transmission electron microscopy, we documented the presence of an exosome isolated from the coculture and other exosome immunogold labeled for exosome markers CD63 ( Figure 4B ). Compared with monoculture, there was greater Wnt5a protein content in exosomes, as evidenced by WB ( Figure 4C ) and immunofluorescent staining ( Figure IXA in the online-only Data Supplement); in contrast, we found no evidence of change in Wnt5a content on coculture in PAH exosomes ( Figure 4D) .
Having quantified the Wnt5a content of exosomes, we next sought to test whether these exosomes have biological activity akin to that seen with recombinant Wnt5a in cell-based assays (Figure 3) . Compared with serum-free medium, incubation of healthy PMVECderived exosomes with siWnt5a PMVECs resulted in a significant increase in pericyte migration and polarization ( Figure 4E, top, panel 3) . Likewise, the addition of whole exosomes to modified wound-healing cocultures ORIGINAL RESEARCH ARTICLE of PAH PMVECs also resulted in a significant increase in pericyte migration and polarization to the endothelial monolayer ( Figure 4E , bottom right). To determine whether the salutary effect of healthy exosomes is dependent on Wnt5a content, we repeated the study using exosomes isolated from siWnt5a PMVECs. Compared with PAH PMVECs treated with siCtrl exosomes, PAH cells treated with siWnt5a exosomes showed a significant reduction in pericyte migration, whereas no difference in polarity was observed in either group (Figure IXB in the online-only Data Supplement). To further confirm the existence and effect of exosomes, we treated coculture with nonfractionated whole media from siWnt5a-treated ECs. We found less pericyte motility and polarization compared with nonfractionated media of siCtrl-treated cells ( Figure X in the online-only Data Supplement).
Mice With Endothelium-Specific Wnt5a Deletion Have Persistent Pulmonary Hypertension and Right Ventricular Dilatation After Recovery From Hypoxia
In an effort to assess the biological contribution of Wnt5a in vivo, we sought to identify a viable mouse model of Wnt5a KO. Global Wnt5a KO (Mouse Genome Informatics No. 1857617) is embryonically lethal as a result of multiple defects incompatible with life, including lung hypoplasia and congenital cardiac anomalies 19 ( Figure XIA in the online-only Data Supplement). To bypass this, we generated a conditional endothelium-specific Wnt5a KO mouse line (Wnt5a ECKO ) in which exon 2 of the Wnt5a gene is flanked by 2 loxP sites ( Figure 5A ). One week after tamoxifen treatment, Wnt5a expression was substantially reduced in ECs, as evidenced by 
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both WB of purified murine PMVECs and lung immunofluorescence ( Figure XIB and XIC in the online-only Data Supplement). We compared the hemodynamic profile of WT and Wnt5a ECKO mice under normoxia, hypoxia (3 weeks of Fio 2 10%), and hypoxia recovery (1 month under normoxia). Although there were no significant differences in right ventricular (RV) systolic pressure between the groups, Wnt5a ECKO mice demonstrated persistently elevated RV systolic pressure after 1 month in recovery ( Figure 5B ). We found that Wnt5a ECKO mice in the recovery group also demonstrated persistent RV hypertrophy, as indicated by a significantly higher Fulton index compared with WT mice ( Figure 5C ). To further assess RV structure and function, echocardiography was performed in WT and Wnt5a ECKO mice across all 3 experimental conditions. Again, we found no difference between WT and Wnt5a ECKO mice until the recovery arm was assessed. Compared with WT mice, Wnt5a ECKO mice in recovery demonstrated RV enlargement ( Figure 5D and 5E and Movies II and III in the onlineonly Data Supplement) and decreased RV function, as evidenced by lower RV fractional shortening ( Figure 5F ) and RV acceleration time over ejection time ( Figure 5G ). Finally, we found no evidence of abnormal heart rate or left ventricular size or function across genotypes or experimental conditions (data not shown).
Wnt5a
ECKO Mice Demonstrate Persistent Loss and Muscularization of Microvessels in Hypoxia Recovery
Given evidence of persistent elevation of RV systolic pressure and RV failure in Wnt5a ECKO mice in hypoxia recovery, we speculated that these mice would also demonstrate abnormalities in pulmonary microvascular structure linked to increased vascular resistance and greater cardiac afterload. To test this, we carried out morphometric studies in lung tissue sections from WT 
ORIGINAL RESEARCH ARTICLE
and Wnt5a ECKO mice under all 3 conditions and compared both the number and extent of muscularization of microvessels (<100 µm).
By counting number of microvessels per 100 alveoli, we found a similar drop in vessel numbers in both groups under hypoxia, which returned to normoxia levels in WT mice after hypoxia recovery but remained persistently reduced in Wnt5a ECKO mice ( Figure 6A ). The same trend was found when the percentage of muscularized vessels was documented. In hypoxia, between 40% and 50% of all vessels were muscularized in both groups; however, on return to normoxia, WT mice demonstrated a significant reduction in muscularized vessels (≈25%), whereas no change was noted in Wnt5a ECKO mice ( Figure 6B ). Further assessment with microcomputed tomography demonstrated a significant reduction in tertiary blood vessel length and number of distal vessels in Wnt5a ECKO mice after recovery ( Figure 6C ). As previously shown by Ricard et al 6 and by the studies included here, pericytes found adjacent to PAH vascular lesions appear detached from the endothelial surface, where they would otherwise be found embedded within the basement membrane. Because inappropriate pericyte coverage of vessels can be associated with small vessel loss through endothelial dysregulation and apoptosis, we stained lung tissue sections from WT and Wnt5a ECKO mice in the hypoxia recovery group with NG2, a marker for pericytes. 20, 21 We found that pericytes in WT mice were found in the immediate perivascular space of microvessels ( Figure 6D, top) . However, as with PAH lungs, pericytes were found dissociated from microvessels and relocated to the surrounding lung parenchyma ( Figure 6D, bottom) , resulting in reduced vessel coverage ( Figure 6E ). We performed confocal imaging of vibratome lung sections (200-300 μm) to perform 3-D reconstruction of microvessels. Indeed, we found that the number of NG2+ pericytes was reduced in endothelium of Wnt5a ECKO recovery mice ( Figure XII and Movie IV in the online-only Data Supplement for control and Movie V in the online-only Data Supplement for Wnt5a ECKO recovery). In addition, the dissociation of pericytes from ECs resulted in increased EC apoptosis, as evidenced via cleaved ADPribosyltransferase 1 (cPARP) staining ( Figure 6F ). No differences were found in normoxia and hypoxia lungs ( Figure  XIII in the online-only Data Supplement).
DISCUSSION
Pericytes are key players in the growth and stability of blood vessels, and their behavior has been the focus of many studies interested in identifying novel therapeutic approaches to treat common vascular disorders (eg, diabetic retinopathy 22, 23 ), as well as in cancer, where aberrant angiogenesis is a major feature of many tumors. [24] [25] [26] The contribution of pericytes to the preservation and proper maintenance of the pulmonary microcirculation has recently become the subject of studies centered on elucidating the link between pericytes and the development of vascular remodeling in PAH. The study by Ricard and colleagues 6 was the first to point out that pericytes appear in a large number around remodeled vessels, whereas they exhibit a proproliferative and promigratory phenotype in vitro reminiscent of PAH pulmonary smooth muscle cells. Indeed, we have found that PAH pericytes exhibit a remarkable proproliferative capacity that translates into smooth muscle cell-like properties such as increased contractility and metabolic alterations in mitochondrial oxidation. 27 However, the perivascular location of PAH pericytes documented by Ricard et al 6 was assessed to be distant from the intima. This is remarkable given that the definition of a pericyte is its close association with ECs, with which they share direct contacts and the basement membrane. 3 This led us to speculate that, in addition to abnormal proliferation and a phenotypic switch, there may be an inherent disorder in cell-cell communication that prevents pericytes from establishing functional connections with ECs.
Our group has shown that PAH pericytes have reduced capacity to associate with PMVECs through a defect in Wnt/PCP activity, which can be partially restored by increasing the expression of specific pathway components. 8 These studies revealed that, in contrast to healthy cells, coculture of PAH pericytes with healthy PMVECs led to formation of smaller tube-like networks with markedly reduced pericyte coverage. The reason for reduced pericyte coverage was found to be an inability for PAH pericytes to polarize and migrate toward PMVECs, as shown by wound coculture assays. The Wnt/PCP pathway is a conserved developmental pathway responsible for coordinating cell organization during tissue morphogenesis. Mutations that reduce Wnt/PCP activity are associated with various clinical musculoskeletal dysplastic syndromes [28] [29] [30] ; however, the impact on development and repair responses in the cardiopulmonary system has yet to be fully characterized. 8 In the present study, we provide evidence that highlights the importance of Wnt5a in the establishment of endothelium-pericyte interactions during repair of the pulmonary circulation. We propose that, in the setting Figure 6 Continued. of optimal cutting temperature (OCT) compound-embedded lung sections from Reox WT (top) and cKO (bottom) mice. Smooth muscle layer was stained with α-smooth muscle actin (a-SMA; red); pericytes (Pcs) were stained with NG2 (magenta); and endothelium was stained with CD31 (green). Scale bar, 25 μm. E, Quantification of NG2-positive cell Pc coverage in vessels from Reox WT and cKO mice. F, Immunofluorescence of OCT-embedded lung sections from Reox WT and cKO mice that stained for CD31 (green), 3G5 (red), and cleaved ADP-ribosyltransferase 1 (cPARP). White arrow indicates 3G5 overlap with cPARP. Scale bar=10 μm. **P<0.01 (unpaired t test). ***P<0.001 (1-way ANOVA with Dunnett posttest). ##P<0.01 vs WT Reox (1-way ANOVA with Bonferroni posttest).
of vascular injury, PMVECs must produce Wnt5a to trigger Wnt/PCP in pericytes to attract them to associate with blood vessels, thereby preserving the number of functional vessels within the microcirculation (model in Figure 7 ). Here, we have selectively used only healthy pericytes in our studies, but we must stress that studies conducted by coculturing PMVECs and PAH pericytes fail to produce any tube-like networks in Matrigel coculture studies (data not shown). We believe this to be evidence that there is synergism in how PMVECs and pericytes interact and that the presence of defects in both cells types is additive, resulting in catastrophic consequences for vessel regeneration.
Establishment of endothelium-pericyte communication is the result of an elegant and dynamic exchange of cytokines by both cell types during the final steps of angiogenesis. Production of platelet-derived growth factor-BB by ECs is responsible for triggering pericyte motility via its interaction with the platelet-derived growth factor receptor 31 ; likewise, transforming growth factor-β production by pericytes is responsible for inducing endothelial quiescence as part of vessel maturation. 32 In addition, a mutual regulatory relationship between Wnt5a and the matricellular protein CCN1 coordinates the EC-pericyte interaction during anigiogenesis. 33 In our present studies, we have found that production of Wnt5a by PMVECs appears to be increased on coculture with pericytes, suggesting that a pericyte-derived factor may be responsible for increasing Wnt5a gene expression in ECs. A major question that remains is, How is Wnt5a production regulated in PMVECs, and why is it suppressed in PAH? A possible explanation comes from DNA sequencing studies that show that the Wnt5a promoter is a nexus for transcription factors that are downstream of multiple signaling pathways involved in the regulation of developmental processes and response to injury. On the basis of the analysis, the Wnt5a promoter has putative binding sites for many signaling pathways such as mitogenactivated protein kinase, bone morphometric protein, transforming growth factor-β, and epidermal growth factor. 34 This is of great relevance because evidence Figure 7 . Proposed model. In the setting of vascular injury, pulmonary microvascular endothelial cells (ECs) produce Wnt5a packaged in exosomes to recruit pericytes (Pcs) to associate with blood vessels, thereby preserving the number of functional vessels within the microcirculation (A). A lack of Wnt5a production significantly impairs establishment of endothelium-Pc interactions, thus resulting in loss of small vessels, leading to pulmonary arterial hypertension (PAH; B) . MVE indicates microvesicles.
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of dysregulation of many of these same pathways has been documented in PAH studies. 35 Another aspect to be considered is that the transcriptional activity of some of these pathways could also be affected by the state of methylation and histone repression of the Wnt5a promoter, a finding that has been documented in cancer studies. 36 Our group is currently engaged in studies to dissect the contribution of epigenetics and signaling cross-talk at the level of the Wnt5a promoter because this strategy could open tantalizing possibilities for augmenting Wnt5a production in PAH.
Wnts have been considered to be autocrine and paracrine factors with limited range. Recently, it has been shown that Wnts can be secreted to the extracellular environment into exosomes, microparticles measuring 50 to 100 nm in size that are responsible for the transport of proteins, RNA, and DNA between cells. 37 In cancer, exosomes containing Wnt11 are released by fibroblasts to activate Wnt/PCP and to drive breast cancer proliferation and invasiveness. 16 Exosomes extracted from the blood of monocrotaline-treated mice can cause PAH when administered into healthy mice, 38 whereas the opposite effect is seen when exosomes from healthy animals are injected into monocrotalinetreated subjects. 39 Thus, we speculated that PMVECs release Wnt5a in exosomes to attract pericytes to pulmonary blood vessels. We acknowledge that the presence of other factors besides Wnt5a is required for attracting pericytes to ECs. Signaling peptides associated with exosomes can be found inside or attached to the outer membrane. We attempted immunogold labeling to identify the location of Wnt5a in exosomes but did not see a signal via transmission electron microscopy. Although it is unlikely that Wnt5a is located in the exosome exterior, this does not rule out that Wnt5a could be located in the lumen, where antibody permeability is reduced. Beyond the studies presented here, we believe that it is important to perform comprehensive genetic and proteomic characterization of the exosome content of healthy and PAH PMVECs, looking at the full range of Wnt-related genes and other markers of signaling activity. This will allow us to identify major candidate pathways that could cross-talk with Wnt signaling to regulate endothelium-pericyte interactions in the pulmonary circulation.
The chronic hypoxia mouse model is a well-established model of experimental pulmonary hypertension that has been used extensively to characterize the contribution of individual genes to PAH pathogenesis. 40 Although it is true that the model does not capture the full spectrum of vascular pathology seen in PAH, lungs explanted from mice exposed to chronic hypoxia demonstrate a significant reduction in the number of alveolar microvessels that correlates with moderate muscularization of precapillary arteries and elevation in pulmonary pressures. 41, 42 It is important to reiterate that the process of pericyte recruitment and establishment of endothelium-pericyte contacts is highly dynamic and takes place over a critical time period of angiogenesis. One limitation of our animal studies is that we measured vessel number and pericyte coverage only at the end of the experimental period (21 days of hypoxia and recovery), not at earlier time points when active angiogenesis and pericyte recruitment are likely taking place. In addition, we cannot rule out that some pericytes may respond to hypoxia by differentiating into smooth muscle-like cells and thereby contribute to muscularization. This possibility has been proposed by several studies and could explain the persistence of muscularization seen in Wnt5a ECKO mice after recovery from hypoxia. 43 It is worth pointing out that loss of Wnt5a also reduced the angiogenic properties of PMVECs, as evidenced in our siRNA-based studies and supported by several studies focused on other vascular beds. 44, 45 Therefore, it is tempting to speculate that Wnt5a may be required not only to recruit pericytes but also to ensure early assembly of blood vessels, a critical step that precedes pericyte recruitment, a major step toward regenerating vessels lost to hypoxia. Finally, it must be pointed out that we observed a greater number of pericytes and greater Wnt5a expression in murine lungs compared with rat or human lung samples. This could very well represent a trait unique to this species and could potentially hint at a greater reparative potential of the mouse lung compared with other species. Ongoing studies looking at progenitor cells in the lung are likely to expand on the role of Wnt5a and Wnt/PCP in this setting.
To the best of our knowledge, our study is the first to uncover a key role for Wnt5a in establishing PMVEC and pericyte interaction in distal vessels, iterating that its loss could contribute to progressive vessel remodeling in PAH. As a modifier of bone morphometric protein signaling in endothelial and smooth muscle cells, 46, 47 Wnt/PCP signaling is a strong candidate to understand how pulmonary angiogenesis is orchestrated. Understanding how Wnt5a and other Wnt/PCP components participate in pulmonary angiogenesis will provide a new paradigm to understand how pulmonary vessels can regenerate after injury, affording new avenues for therapeutic interventions aimed at reversing the progression of PAH. Beyond this, it is plausible that Wnt/ PCP could play a similar role in other diseases in which abnormal endothelium-pericyte interactions occur and therapeutic interventions may serve to alter the natural disease course.
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